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Goals and Programs of the
Laboratory of Environmental
Mutagenesis
by H. V. Malling*
The Laboratory of Environmental Mutagenesis
(LEM) is one of the three research laboratories at
the National Institute of Environmental Health
Sciences.
In the formation of the programs for such a
laboratory, it is important to set some goals and
then to ask the question, "How can these goals be
achieved?"
The societal goal for the LEM is the prevention
of increased frequency of genetic disease in the
human population. That goal covers the waterfront,
however, and the LEM cannot possibly cover all
the scientific areas necessary to accomplish that
goal. Independently of how large we will grow,
there will be areas left out. The next questions then
become, "Which parts are we going to do and how
are we going to do them?" Ourapproaches include:
(1) development of short-term testing systems for
mutagenic activity; (2) development of mammalian
mutation systems which can be used to predict the
risk for the human population; (3) development of
monitoring systems for detection of mutations in
the human population; and (4) evaluation of the fit-
ness of populations with an increased number of
mutations in the gene pool.
Let us go back to the development of sort-term
tests for mutagenesis screening: I will describe
what problems we are faced with in the develop-
ment ofthe tests.
Some pollutants in the environment are neither
mutagenic nor carcinogenic by themselves but can
be converted by mammalian metabolism to high-
ly reactive and genetically active metabolites. Mi-
croorganisms have only a fraction of the toxi-
fication-detoxification mechanisms that a mam-
mal has. To screen for mutagenicity in mammals, is
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extremely expensive and time-consuming, whereas
many quantitative mutation systems exist today in
microorganisms. Therefore, in the development of
the short-term tests we have to combine the micro-
bial mutation system with the drug metabolism of
the higher animal. This can be done by homog-
enizing organs of laboratory animals and preparing
various enzyme fractions and testing them for their
ability to form active metabolites from inactive par-
ent compounds. Drs. Zeiger, Ong, and Callen are
deeply involved in this problem in collaboration
with scientists in the Laboratory ofPharmacology.
Homogenizing an organ and fractionating it into
various parts can destroy the efficiency of the acti-
vation pathways and balance between the toxifica-
tion and detoxification mechanisms. This problem
can be avoided by injecting the indicator organism
into the bloodstream of the animal and treating the
animal with the compound under test and later
isolating the microorganism and measuring muta-
tions in them.
The microorganisms, however, are not inert
components lacking any metabolism. Since they do
have their own activation and detoxification sys-
tems, it is very important to know which part ofthe
activation is due to the microorganism and which
part is due to mammalian metabolism. This problem
is being studied in collaboration with Drs. Philpot
and Chhabra in the Laboratory ofPharmacology.
Because microorganisms have a cell wall which
can prevent penetration of the cells by certain
chemicals, some chemicals which are active in
mammalian cells are inactive in microorganisms.
To circumvent this problem in yeast, Dr. Callen is
attempting to isolate yeast cells which are more
permeable.
Microbial systems alone obviously cannot be
used to predict the genetic hazard to the human
population from an exposure to environmental
agents.
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very important mutation systems in mammals is
that involving induced transmissible translocations.
A government document on mutagenesis (1) states
that a compound which increases the frequency of
translocation in mammals must be considered a
human mutagen. This is the type of chromosomal
mutation in the human population that results in
various types of mental retardation. Drs. Sheridan
and Michelmann are studying the effect of the un-
balanced genome in the offspring ofa translocation
heterozygote on the development of the embryo.
Hopefully, these studies will lead to a much deeper
understanding of the hazard or the health of the
individuals ofthe various types oftranslocations.
Dr. Valcovic and I have developed the biochem-
ical specific locus mutation system in which muta-
tions can be detected in specific enzymes. At the
present we are only working with nine different
genes, but have a breeding program with The Jack-
son Laboratory to increase the number to 26 and
later to 50. Dr. Soares has demonstrated that the
system is capable ofdetecting mutations induced by
achemical mutagen, triethylenemelamine (TEM).
In contrast to other specific locus mutation sys-
tems in mammals, the biochemical specific locus
mutation system has a close parallel in man, be-
cause humans and mice have many ofthe same en-
zymes. This system will most likely add to our abil-
ity to make predictions about the genetic hazard of
a certain compound to the human population from
our animal data.
In order to do this with even more reliability we
have just started a unit, headed by Dr. Steven Li,
for sequencing proteins and later RNA an DNA.
Thus unit will also sequence the mutant proteins to
identify the genetic alteration in mutants. The dif-
ferent type of genetic alterations could have quite
different effects on the individuals which carry
them. Dr. Neel, in Ann Arbor, Michigan, is trying
to monitor the human population for mutations by
enzyme analysis (2). Many ofthe enzymes in which
we are measuring mutations overlap with Dr.
Neel's battery of enzymes. To a certain degree we
are providing the background data which will help
to evaluate the findings inthe human population.
Knowingly or unknowingly, fractions of the
human population are exposed to hazardous com-
pounds. It is, therefore, important to have a system
for detection ofmutations in the human population.
Let us first consider Neel's system in which the
offspring are screened to determine the mutant fre-
quency of the parents. This system requires
perhaps a million babies to come up with any statis-
tical significance on a reasonable increase in mu-
tation frequency. This system can give a general
trend in the population; and while that is important,
the epidemiological unit we are working with is too
gross to pinpoint specific hazardous environments
smaller in area than New York. This problem oc-
curs because the individual is just one event. If in-
stead we could estimate the mutation frequency on
an individual, we would be in much better shape.
To do this we are developing systems to measure
mutations in single cells in vivo. Here we are limited
too; there are only two types of samples of single
cells we can get easily from humans, namely, the
cells inblood and semen.
In collaboration with Dr. Stamatoyannopoulos at
the University ofWashington, Seattle, we have de-
veloped a technique for detecting RBC's which
carry the sickle cell hemoglobin. The technique is
based on development of monospecific antibodies
to S hemoglobin and labeling it with a fluorescent
molecule. The only cell which will react with this
antibody is the sickle cell. In any normal individual
there are approximately 10-7 sickle cells. This
number could be expected to go up by exposure to
mutagens. The mutation which results in S
hemoglobin is only one type of many hemoglobin
variants. Dr. Stamatoyannopoulos, therefore, is
making antibodies to many other hemoglobin mu-
tants. This will increase the sensitivity of the sys-
tem. In order to interpret the data we need animal
model systems. Various strains ofmice contain dif-
ferent hemoglobins, and Dr. Ansari is utilizing
these differences to develop such model systems.
Around the midpiece of sperm is a sheet of
mitochondria containing enzymes which can be de-
tected by histochemical stains. By using specific
inhibitors of these enzymes it may be possible to
detect the mutation resistance to the inhibitor. We
hope to use this mutation-detecting technique to
develop a monitoring system for the human popula-
tion.
One ofthe advantages ofthe RBC system and the
sperm system is that both are nondestructive to the
animal; and the detection of mutations can, there-
fore, "piggyback" on any bigger chronic feeding
study. In this way the mutationfrequencies can also
be correlated with other toxicological phenomena
such as tumorgenesis, etc. When this correlation is
known, the monitoring system based on detection
of mutants in the RBC's could, therefore, also
serve as an early warning system for certain cancers
in the human population.
There are many harmful chemicals that we can-
not avoid in the environment, such as SO2, nitrogen
oxides, etc., some ofwhich may be mutagenic. The
human society must set limits to chemical exposure
as was done for irradiation. In order to evaluate the
health hazard imposed on the human population by
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evaluate the fitness of individuals carrying these
mutations in their genome. Drosophila is the only
available organism in which this can be done. Drs.
Langley and Voelker are comparing the fitness of
the mutations which exist in the natural population
and, therefore, has been exposed to some selection
with the fitness of newly induced mutations. The
data which will come out of these comparisons
should help us evaluate the genetic hazard imposed
on the human population by exposure to mutagens.
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